Works matching DE "GLUCAGON-like peptide-1 receptor"
Results: 1947
SGLT2i and GLP1RA effects in patients followed in a hospital diabetology consultation.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 11, p. 1081, doi. 10.1080/17512433.2024.2421872
- By:
- Publication type:
- Article
Semaglutide and smoking cessation in individuals with type 2 diabetes mellitus: there is no smoke without fire!
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 11, p. 1009, doi. 10.1080/17512433.2024.2418398
- By:
- Publication type:
- Article
Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 8, p. 721, doi. 10.1080/17512433.2024.2363838
- By:
- Publication type:
- Article
Advancements in the management of obesity: a review of current evidence and emerging therapies.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2024, v. 19, n. 3, p. 257, doi. 10.1080/17446651.2024.2347258
- By:
- Publication type:
- Article
Кардіальні захворювання та хронічна хвороба нирок - фатальним альянс чи нові можливості в лікуванні? (Огляд літератури).
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
Shortages of benzathine benzylpenicillin G in Australia highlight the need for new sovereign manufacturing capability.
- Published in:
- Medical Journal of Australia, 2025, v. 222, n. 5, p. 223, doi. 10.5694/mja2.52590
- By:
- Publication type:
- Article
Correction: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and cardiometabolic protection: historical development and future challenges.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Comparison of Exendin-4 and Its Single Amino Acid Substitutions as Parent Peptides for GLP-1 Receptor Imaging Probes.
- Published in:
- Molecules, 2025, v. 30, n. 5, p. 1011, doi. 10.3390/molecules30051011
- By:
- Publication type:
- Article
Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 476, doi. 10.1093/jnci/djae260
- By:
- Publication type:
- Article
Beyond Diabetes: Semaglutide's Role in Modulating Mood Disorders through Neuroinflammation Pathways.
- Published in:
- Cellular & Molecular Neurobiology, 2025, v. 45, n. 1, p. 1, doi. 10.1007/s10571-025-01534-4
- By:
- Publication type:
- Article
The Impact of Obesity Treatments on Bone Health: Insights from Recent Research.
- Published in:
- Journal of Obesity & Metabolic Syndrome, 2025, v. 34, n. 1, p. 1, doi. 10.7570/jomes25001
- By:
- Publication type:
- Article
Author Correction: Monocytes to Apolipoprotein A1 ratio is associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Food Demand in a Post-Ozempic World.
- Published in:
- Choices: The Magazine of Food, Farm & Resource Issues, 2025, v. 40, n. 1, p. 1
- By:
- Publication type:
- Article
GABA and GLP-1 receptor agonist combination therapy modifies diabetes and Langerhans islet cytoarchitecture in a rat model of Wolfram syndrome.
- Published in:
- Diabetology & Metabolic Syndrome, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13098-025-01651-6
- By:
- Publication type:
- Article
Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes.
- Published in:
- Endocrinology & Metabolism, 2025, v. 40, n. 1, p. 156, doi. 10.3803/EnM.2024.2150
- By:
- Publication type:
- Article
Tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis.
- Published in:
- Endocrinology & Metabolism, 2025, v. 40, n. 1, p. 112, doi. 10.3803/EnM.2024.2164
- By:
- Publication type:
- Article
Highlights of the Most Recent American Diabetes Association Guidelines: From Evidence to Practice.
- Published in:
- Endocrinology & Metabolism, 2025, v. 40, n. 1, p. 67, doi. 10.3803/EnM.2025.2329
- By:
- Publication type:
- Article
Obesity A therapeutic target in people with cardiovascular disease.
- Published in:
- Medicine Today, 2024, v. 25, n. 12, p. 23
- By:
- Publication type:
- Article
Effects of Anti-Diabetic Drugs on Erectile Dysfunction: A Systematic Review and Meta-Analysis.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2025, v. 18, p. 467, doi. 10.2147/DMSO.S503216
- By:
- Publication type:
- Article
Efficacy and Safety of Glucagon Like Peptide-1 Receptor Agonism Based Therapies in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis.
- Published in:
- Indian Journal of Endocrinology & Metabolism, 2025, v. 29, n. 1, p. 4, doi. 10.4103/ijem.ijem_365_24
- By:
- Publication type:
- Article
GLP-1 receptor agonists—another promising therapy for Alport syndrome?
- Published in:
- Journal of Rare Diseases, 2025, v. 4, n. 1, p. 1, doi. 10.1007/s44162-024-00065-8
- By:
- Publication type:
- Article
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 238, doi. 10.3390/pharmaceutics17020238
- By:
- Publication type:
- Article
Exploring the Putative Involvement of MALAT1 in Mediating the Beneficial Effect of Exendin-4 on Oleic Acid-Induced Lipid Accumulation in HepG2 Cells.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 370, doi. 10.3390/biomedicines13020370
- By:
- Publication type:
- Article
Diabetes Mellitus in Kidney Transplant Recipients: New Horizons in Treatment.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1048, doi. 10.3390/jcm14041048
- By:
- Publication type:
- Article
A Hypothesis That Glucagon-like Peptide-1 Receptor Agonists Exert Immediate and Multifaceted Effects by Activating Adenosine Monophosphate-Activate Protein Kinase (AMPK).
- Published in:
- Life (2075-1729), 2025, v. 15, n. 2, p. 253, doi. 10.3390/life15020253
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 (SGLT2) inhibitors and risk of chronic kidney disease–mineral and bone disorders in patients with type 2 diabetes mellitus and stage 1–3 chronic kidney disease.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2025, v. 197, n. 7, p. E178, doi. 10.1503/cmaj.240922
- By:
- Publication type:
- Article
Myocardial Protection Against Ischemia-Reperfusion Injury by GLP-1: Molecular Mechanisms.
- Published in:
- Metabolic Syndrome & Related Disorders, 2012, v. 10, n. 6, p. 387, doi. 10.1089/met.2012.0095
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonists for Abdominal Aortic Aneurysm?
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 13, doi. 10.1007/s10557-024-07647-0
- By:
- Publication type:
- Article
Impact of Heart Failure History at Baseline on Cardiovascular Effects of GLP-1 Receptor Agonists in Type 2 Diabetes: a Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 4, p. 739, doi. 10.1007/s10557-023-07432-5
- By:
- Publication type:
- Article
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery Disease.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 6, p. 1161, doi. 10.1007/s10557-021-07160-8
- By:
- Publication type:
- Article
New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 1, p. 10, doi. 10.1007/s10157-012-0709-0
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors and the risk of venous thromboembolism: A nationwide population‐based study and meta‐analysis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 2, p. 1, doi. 10.1002/dmrr.3739
- By:
- Publication type:
- Article
Effects of treatment with Glucagon‐like peptide‐1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta‐analysis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 7, p. 1, doi. 10.1002/dmrr.3680
- By:
- Publication type:
- Article
Pleiotropic effects of GLP‐1 receptor agonists on peripheral artery disease: Is there any hope?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 7, p. 1, doi. 10.1002/dmrr.3627
- By:
- Publication type:
- Article
Changing the approach to type 2 diabetes treatment: A comparison of glucagon‐like peptide‐1 receptor agonists and sulphonylureas across the continuum of care.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 7, p. 1, doi. 10.1002/dmrr.3434
- By:
- Publication type:
- Article
GLP‐1 RA and atrial fibrillation in the cardiovascular outcome trials.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 5, p. 1, doi. 10.1002/dmrr.3436
- By:
- Publication type:
- Article
A multifaceted approach for management of prediabetes and its associated cardiovascular risk.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Liraglutide on Osteoporosis in a Rat Model of Type 2 Diabetes Mellitus: A Histological, Immunohistochemical, and Biochemical Study.
- Published in:
- Microscopy & Microanalysis, 2023, v. 29, n. 6, p. 2053, doi. 10.1093/micmic/ozad102
- By:
- Publication type:
- Article
Sodium glucose cotransporter 2 inhibitors and gout risk: a sequence symmetry analysis.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 9, p. 2469, doi. 10.1007/s10067-023-06647-z
- By:
- Publication type:
- Article
Duodenal-jejunal bypass changes the composition of the gut microbiota.
- Published in:
- Surgery Today, 2017, v. 47, n. 1, p. 137, doi. 10.1007/s00595-016-1373-x
- By:
- Publication type:
- Article
Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats.
- Published in:
- Surgery Today, 2016, v. 46, n. 9, p. 1099, doi. 10.1007/s00595-015-1287-z
- By:
- Publication type:
- Article
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).
- Published in:
- JMIR Research Protocols, 2022, v. 11, n. 7, p. 1, doi. 10.2196/34206
- By:
- Publication type:
- Article
The Ups and Downs of Non-Insulin Therapies: The Agony of Choice.
- Published in:
- Clinical Management Issues, 2019, v. 13, n. 1, p. 19, doi. 10.7175/cmi.v13i1.1426
- By:
- Publication type:
- Article
'No Observed Increase' in Pancreatic Cancer Among Patients with Type 2 Diabetes on GLP-1RAs.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 37
- By:
- Publication type:
- Article
GLP-1RAs May Offer 'Hepatoprotective' Benefit for Diabetes, Alcohol-Related Liver Disease.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 32
- By:
- Publication type:
- Article
'No Observed Increase' in Pancreatic Cancer Among Patients With Type 2 Diabetes on GLP-1RAs.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 11, p. 32
- By:
- Publication type:
- Article
GLP-1RA Use Linked With Risk for Food Retention in Single Endoscopic Procedures.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 11, p. 14
- By:
- Publication type:
- Article
'Encouraging' Data: GLP-1RAs Linked to Lower Risk for Cirrhosis in MASLD, Type 2 Diabetes.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 6, p. 36
- By:
- Publication type:
- Article
GLP-1RA Use in MAFLD, Obesity Lowers Mortality, 'Provides Cardiovascular Benefits'.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 6, p. 33
- By:
- Publication type:
- Article